Invention Grant
- Patent Title: Neuregulin based methods for treating heart failure
-
Application No.: US15601856Application Date: 2017-05-22
-
Publication No.: US11246909B2Publication Date: 2022-02-15
- Inventor: Mingdong Zhou
- Applicant: Zensun (Shanghai) Science & Technology, Co., Ltd.
- Applicant Address: CN Shanghai
- Assignee: Zensun (Shanghai) Science & Technology, Co., Ltd.
- Current Assignee: Zensun (Shanghai) Science & Technology, Co., Ltd.
- Current Assignee Address: CN Shanghai
- Agency: Jones Day
- Main IPC: A61K38/16
- IPC: A61K38/16 ; A61K38/18 ; C07K14/475 ; G06K9/00 ; H01L27/20
Abstract:
The present invention features methods of treating patients with chronic heart failure by administering a neuregulin polypeptide within a dosage range which is both effective and safe.
Public/Granted literature
- US20180104311A1 NEUREGULIN BASED METHODS FOR TREATING HEART FAILURE Public/Granted day:2018-04-19
Information query
IPC分类:
